Cancer Discov. 2013 Jun;3(6):OF8. doi: 10.1158/2159-8290.CD-ND2013-013. Epub 2013 Apr 18.
Phase I trials of 2 treatments for recurrent ovarian cancer-a 2-step immunotherapy treatment and an antibody-drug conjugate-demonstrated promising early results in delaying recurrence, in work presented at the American Association for Cancer Research Annual Meeting 2013.
在 2013 年美国癌症研究协会年会上展示的两项复发性卵巢癌治疗的 I 期临床试验——两步免疫治疗和抗体药物偶联物——显示出有希望的早期结果，可延迟复发。
